Skip to content

Scapular Dyskinesis With Impingement Syndrome

Diagnosis and Treatment of Scapular Dyskinesis Combined With Impingement Syndrome of Shoulder

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07001228
Enrollment
360
Registered
2025-06-03
Start date
2025-05-29
Completion date
2027-05-31
Last updated
2025-06-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Impingement Syndrome, Shoulder, Scapular Dyskinesis

Brief summary

The goal of this study is to diagnose scapular dyskinesis-which can appear as a cause or result of various shoulder disorders-through screening tests in patients with shoulder impingement syndrome, the most common shoulder condition. By identifying scapular dyskinesis, the study aims to maximize treatment outcomes through appropriate rehabilitative exercise therapy.

Interventions

BEHAVIORALSD rehabilitation

For shoulder impingement syndrome, the standard rehabilitation protocol involves administering a subacromial steroid injection at the initial outpatient visit, followed by stick exercises to restore joint mobility starting three weeks later. Four weeks after initiating the stick exercises, rotator cuff strengthening exercises using therabands are introduced and maintained for a duration of six weeks. For SD rehabilitation, shoulder external rotation, push up plus, and shoulder rolls were performed. In the experimental group, rehabilitation for scapular dyskinesis will begin at the second outpatient visit, which takes place three weeks after the subacromial steroid injection.

BEHAVIORALNo SD rehabilitation

For shoulder impingement syndrome, the standard rehabilitation protocol involves administering a subacromial steroid injection at the initial outpatient visit, followed by stick exercises to restore joint mobility starting three weeks later. Four weeks after initiating the stick exercises, rotator cuff strengthening exercises using therabands are introduced and maintained for a duration of six weeks. In the sham group, rehabilitation for scapular dyskinesis will not begun at the second outpatient visit, which takes place three weeks after the subacromial steroid injection.

Sponsors

Chuncheon Sacred Heart Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Masking description

The investigators plan to enroll patients who consent to participate in the study and allocate them into two groups using a random sequence generator. A random allocation table will be created and managed by a third party who is not involved in the study. When planning the treatment method, group assignment will be requested from this third party holding the allocation table, ensuring that the allocator is blinded to the upcoming group assignments in advance. Treatment in each group will be administered consistently according to a pre-agreed protocol, and follow-up will also be conducted using the same method in both groups.

Intervention model description

This study involves patients who visited the outpatient clinic with unilateral shoulder pain persisting for more than three months and were diagnosed with unilateral shoulder impingement syndrome based on MRI findings. Only patients who provided informed consent were enrolled in the study. A total of 320 patients with unilateral shoulder impingement syndrome from Chuncheon Sacred Heart Hospital were included. The participants were randomly assigned into two groups of 160 patients each. Both groups underwent rehabilitation for shoulder impingement syndrome; however, the control group (Group 1) did not receive rehabilitation for scapular dyskinesis, while the experimental group (Group 2) did receive rehabilitation targeting scapular dyskinesis.

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Inclusion Criteria Patients diagnosed with unilateral shoulder impingement syndrome in the outpatient clinic (based on clinical symptoms and MRI) from the IRB approval date until March 1, 2027 Individuals who provided written informed consent after receiving a thorough explanation of the study prior to any procedures Age 20 years or older 2.

Exclusion criteria

Individuals who did not receive a subacromial steroid injection for shoulder impingement syndrome Individuals with a history of surgical treatment or fracture in the affected shoulder Individuals who refused to participate in the study Individuals with neurological disorders affecting the ipsilateral upper extremity

Design outcomes

Primary

MeasureTime frameDescription
visual analog pain scale (VAS)Initial, 3, 7, 13 weeks0-10, 0: not satisfied, 10: very much satisfied

Secondary

MeasureTime frameDescription
American Shoulder and Elbow Surgeons' (ASES) scoreInitial, 3, 7,13 weeks0-100
Constant scoreInitial, 3, 7, 13 weeks0-100

Countries

South Korea

Contacts

Primary ContactJung-Taek Hwang, MD, PhD
drakehjt@hanmail.net+82332405197
Backup ContactSu-Jung Seo, PhD
asasa4444@naver.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026